Acid sphingomyelinase is a gatekeeper of placental labyrinthine architecture and function
Development · 2025
DOI: 10.1242/dev.204425 ↗At a glance
Journal article in Development, 2025. Written by Isidora Rovic and 8 co-authors. Institution: Department of Physiology, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario M5S 1A8, Canada. Major MEDLINE topics: Sphingomyelin Phosphodiesterase, Placenta. Cited 2 times so far (Crossref); 37 references. The full text is freely available (open access, CC BY 4.0). Funded by: Natural Sciences and Engineering Research Council of Canada, CIHR, Canadian Institutes of Health Research.
Abstract (original language)
Sphingolipids are a class of bioactive signaling lipids that regulate an array of fundamental cellular processes, including cell survival, proliferation and differentiation. Deficiency of acid sphingomyelinase – an enzyme of the sphingolipid metabolic pathway – has been previously implicated in human placental pathologies. We demonstrate that acid sphingomyelinase (Smpd1) is required for normal placental development in the mouse, and its deficiency results in an intrauterine growth restriction phenotype. Smpd1-deficient placentas display several anatomical abnormalities, including a reduced labyrinth compartment and increased fetal-maternal interhaemal distance. Finally, we observed several hallmarks of defective autophagy and lysosomal impairment in Smpd1−/− placentas, which could explain the inability of Smpd1−/− trophoblast to respond to nutrient starvation. Fetal growth restriction could not be rescued by transfer of Smpd1-deficient embryos into a wild-type uterine environment; however, restoration of transcription factor EB phosphorylation was detected. Thus, we conclude that, due to a smaller labyrinthine area, Smpd1 deficiency leads to a decrease in exchange between maternal and fetal blood space, limiting the supply of nutrients to the fetus and resulting in growth restriction.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Physiology, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario M5S 1A8, Canada.
- Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario M5G 1X5, Canada.
- Mouse Imaging Centre, 25 Orde Street, Toronto, Ontario M5T 3H7, Canada.
- Translational Medicine, Hospital for Sick Children, Toronto, Ontario M5G 0A4, Canada.
- Department of Medical Biophysics, University Health Network-Toronto General Hospital, Toronto, Ontario M5G 1L7, Canada.
- Department of Obstetrics and Gynecology, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario M5G 1E2, Canada.
ORCID profiles: Andrea Jurisicova
Funding
- Natural Sciences and Engineering Research Council of Canada
- CIHR
- Canadian Institutes of Health Research
Cite
APA
Rovic, I., Szelag, K., Li, H., McQuaid, R., Sugin, S., Wu, Q., Theodora, N., Sled, J., & Jurisicova, A. (2025). Acid sphingomyelinase is a gatekeeper of placental labyrinthine architecture and function. Development. https://doi.org/10.1242/dev.204425
Vancouver
Rovic I, Szelag K, Li H, McQuaid R, Sugin S, Wu Q, et al. Acid sphingomyelinase is a gatekeeper of placental labyrinthine architecture and function. Development. 2025. doi:10.1242/dev.204425
BibTeX
@article{Rovic2025,
author = {Rovic, Isidora and Szelag, Katherine and Li, Han and McQuaid, Rosanne and Sugin, Sara and Wu, Que and Theodora, Natalia and Sled, John and Jurisicova, Andrea},
title = {Acid sphingomyelinase is a gatekeeper of placental labyrinthine architecture and function},
journal = {Development},
year = {2025},
doi = {10.1242/dev.204425}
}
EUVIMED